555 related articles for article (PubMed ID: 31755069)
1. Efficacy of Aspirin in the Primary Prevention of Cardiovascular Diseases and Cancer in the Elderly: A Population-Based Cohort Study in Korea.
Jung M; Lee S
Drugs Aging; 2020 Jan; 37(1):43-55. PubMed ID: 31755069
[TBL] [Abstract][Full Text] [Related]
2. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
[TBL] [Abstract][Full Text] [Related]
3. Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.
; Bowman L; Mafham M; Wallendszus K; Stevens W; Buck G; Barton J; Murphy K; Aung T; Haynes R; Cox J; Murawska A; Young A; Lay M; Chen F; Sammons E; Waters E; Adler A; Bodansky J; Farmer A; McPherson R; Neil A; Simpson D; Peto R; Baigent C; Collins R; Parish S; Armitage J
N Engl J Med; 2018 Oct; 379(16):1529-1539. PubMed ID: 30146931
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
Lee J; Lee S
Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
[TBL] [Abstract][Full Text] [Related]
5. Aspirin Efficacy in Primary Prevention: A Meta-analysis of Randomized Controlled Trials.
Barbarawi M; Kheiri B; Zayed Y; Gakhal I; Al-Abdouh A; Barbarawi O; Rashdan L; Rizk F; Bachuwa G; Alkotob ML
High Blood Press Cardiovasc Prev; 2019 Aug; 26(4):283-291. PubMed ID: 31280451
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database.
Noh Y; Lee J; Shin S; Lim HS; Bae SK; Oh E; Kim GJ; Kim JH; Lee S
PLoS One; 2016; 11(3):e0150475. PubMed ID: 26939062
[TBL] [Abstract][Full Text] [Related]
7. Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Japanese Patients with Atherosclerotic Risk Factors: Subanalysis of a Randomized Clinical Trial (JPPP-70).
Sugawara M; Goto Y; Yamazaki T; Teramoto T; Oikawa S; Shimada K; Uchiyama S; Ando K; Ishizuka N; Murata M; Yokoyama K; Uemura Y; Ikeda Y;
Am J Cardiovasc Drugs; 2019 Jun; 19(3):299-311. PubMed ID: 30565155
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Aspirin on the Primary Prevention of Major Adverse Cardiac and Cerebrovascular Events in Chinese Older Adults: A Registration Study.
Sun X; Sun R; Zhang L
Drugs Aging; 2022 Jan; 39(1):97-106. PubMed ID: 34866173
[TBL] [Abstract][Full Text] [Related]
9. All-cause mortality following low-dose aspirin treatment for patients with high cardiovascular risk in remote Australian Aboriginal communities: an observational study.
Zhao Y; Jeyaraman K; Burgess P; Connors C; Guthridge S; Maple-Brown L; Falhammar H
BMJ Open; 2020 Jan; 10(1):e030034. PubMed ID: 31900264
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of aspirin and statins in primary prevention of cardiovascular mortality in uncomplicated hypertensive participants: a Korean national cohort study.
Lee CJ; Oh J; Lee SH; Kang SM; Choi D; Kim HC; Park S
J Hypertens; 2017 May; 35 Suppl 1():S33-S40. PubMed ID: 28129248
[TBL] [Abstract][Full Text] [Related]
11. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
12. A long-term risk-benefit analysis of low-dose aspirin in primary prevention.
Wu IC; Hsieh HM; Yu FJ; Wu MC; Wu TS; Wu MT
Eur J Clin Invest; 2016 Feb; 46(2):130-40. PubMed ID: 26640116
[TBL] [Abstract][Full Text] [Related]
13. Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis.
Butalia S; Leung AA; Ghali WA; Rabi DM
Cardiovasc Diabetol; 2011 Apr; 10():25. PubMed ID: 21453547
[TBL] [Abstract][Full Text] [Related]
14. Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer.
Puhan MA; Yu T; Stegeman I; Varadhan R; Singh S; Boyd CM
BMC Med; 2015 Oct; 13():250. PubMed ID: 26423305
[TBL] [Abstract][Full Text] [Related]
15. Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients--a longitudinal observational study.
Leung WY; So WY; Stewart D; Lui A; Tong PC; Ko GT; Kong AP; Ma RC; Chan FK; Yang X; Chiang SC; Chan JC
Cardiovasc Diabetol; 2009 Oct; 8():57. PubMed ID: 19878541
[TBL] [Abstract][Full Text] [Related]
16. The Use of Aspirin Increases the Risk of Major Adverse Cardiac and Cerebrovascular Events in Hypertensive Patients with Obstructive Sleep Apnea for the Primary Prevention of Cardiovascular Disease: A Real-World Cohort Study.
Li N; Wen W; Cai X; Zhu Q; Hu J; Heizhati M; Yuan Y; Gan L; Dang Y; Yang W; Hong J; Zhang X
J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498638
[TBL] [Abstract][Full Text] [Related]
17. The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION Trial.
Solomon DH; Libby P; Yeomans ND; Wang Q; Wolski KE; Nissen SE; Husni ME
Rheumatology (Oxford); 2018 Aug; 57(8):1364-1369. PubMed ID: 29688503
[TBL] [Abstract][Full Text] [Related]
18. Benefits and Risks Associated with Low-Dose Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Control Trials and Trial Sequential Analysis.
Wang M; Yu H; Li Z; Gong D; Liu X
Am J Cardiovasc Drugs; 2022 Nov; 22(6):657-675. PubMed ID: 35570250
[TBL] [Abstract][Full Text] [Related]
19. Myocardial infarction and gastro-intestinal bleeding risks associated with aspirin use among elderly individuals with type 2 diabetes.
Sirois C; Moisan J; Poirier P; Grégoire JP
Ann Med; 2014 Aug; 46(5):335-40. PubMed ID: 24785356
[TBL] [Abstract][Full Text] [Related]
20. Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials.
Seidu S; Kunutsor SK; Sesso HD; Gaziano JM; Buring JE; Roncaglioni MC; Khunti K
Cardiovasc Diabetol; 2019 Jun; 18(1):70. PubMed ID: 31159806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
